Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Celgene
Company Monitoring Page for Celgene
latest headlines for company on cafepharma
Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit
Reuters
Thu, 09/7/23 - 10:57 pm
Tags:
Bristol Myers Squibb
,
Celgene
,
patents
,
legal
,
Pomalyst
Bristol Myers, BeiGene end legacy Celgene deal with settlement years after China ban
Fierce Pharma
Thu, 08/3/23 - 11:22 am
Tags:
Bristol Myers Squibb
,
BeiGene
,
Celgene
BMS re-ups 'highly productive' legacy neurodegeneration partnership with Evotec for $50M upfront
Fierce Biotech
Tue, 03/28/23 - 10:44 pm
Tags:
Bristol Myers Squibb
,
Celgene
,
Evotec
,
neurodegenerative disease
Bristol Myers dodges one $6.4B Celgene buyout CVR suit, but the battle is far from over
Fierce Pharma
Thu, 03/2/23 - 10:45 pm
Tags:
Bristol Myers Squibb
,
Breyanzi
,
Celgene
,
legal
,
M&A
,
CVRs
'Monopoly' allowed Bristol Myers and generics makers to 'steal' from Revlimid purchasers, lawsuit says
Fierce Pharma
Wed, 11/23/22 - 07:33 am
Tags:
Bristol Myers Squibb
,
Celgene
,
Revlimid
,
patents
,
generics
Federal judge denies Bristol Myers' attempt to avoid Celgene shareholder lawsuit
Endpoints
Mon, 06/27/22 - 07:02 pm
Tags:
Celgene
,
Bristol Myers Squibb
,
Breyanzi
,
legal
Bristol Myers dusts off an old Celgene chemotherapy for use in children with a rare blood cancer
Endpoints
Mon, 05/23/22 - 06:51 pm
Tags:
Bristol Myers Squibb
,
Celgene
,
chemotherapy
,
FDA
,
Vidaza
,
MDS
Bristol Myers Squibb, after massive Celgene takeover, plots $15B buyback plan
Fierce Pharma
Tue, 12/14/21 - 10:43 am
Tags:
Bristol Myers Squibb
,
Celgene
,
M&A
,
stock buybacks
Next-gen psoriasis drug rivalry between Bristol Myers and Nimbus spills into a legal battle
Endpoints
Tue, 08/17/21 - 10:56 pm
Tags:
Bristol Myers Squibb
,
Celgene
,
Nimbus Therapeutics
,
psoriasis
,
deucravacitinib
Bristol Myers inks another Revlimid patent settlement—this time with Sun Pharma—as copycats near
Fierce Pharma
Tue, 06/22/21 - 10:49 pm
Tags:
Bristol Myers Squibb
,
Celgene
,
Revlimid
,
generics
,
Sun Pharma
,
patents
Bristol-Myers is sued for $6.4 billion over delayed cancer drug
Reuters
Thu, 06/3/21 - 11:14 pm
Tags:
Bristol Myers Squibb
,
Breyanzi
,
legal
,
Celgene
Bristol Myers expands Celgene-era deal with Exscientia, taking its AI R&D engine to the next step
Endpoints
Wed, 05/19/21 - 10:33 am
Tags:
Bristol Myers Squibb
,
Exscientia
,
R&D
,
Celgene
,
M&A
,
artificial intelligence
Bristol’s buy moves it to the top of the sales charts
EP Vantage
Tue, 05/18/21 - 10:53 am
Tags:
Celgene
,
Bristol-Myers Squibb
,
M&A
,
sales reps
How Bristol Myers Squibb's Celgene Buyout Continued to Pay Off in Q4
Motley Fool
Thu, 02/4/21 - 08:07 pm
Tags:
Bristol-Myers Squibb
,
Celgene
,
earnings
,
M&A
Bristol Myers Squibb turns in priority review voucher for supplemental indication on an old Celgene drug
Endpoints
Wed, 02/3/21 - 10:55 am
Tags:
Bristol-Myers Squibb
,
Celgene
,
FDA
,
ulcerative colitis
,
priority review
,
Zeposia
FDA blasts Lonza facility in Form 483 that derailed Bristol Myers' plan of liso-cel nod by 2020
Fierce Pharma
Fri, 01/29/21 - 09:57 am
Tags:
Bristol-Myers Squibb
,
Celgene
,
liso-cel
,
M&A
,
CAR-T
BMS/Celgene merger payout evaporates as CVR deadline passes
Pharmaforum
Mon, 01/4/21 - 10:21 am
Tags:
Celgene
,
Bristol-Myers Squibb
,
FDA
,
CVRs
An FDA inspection raises questions about Bristol Myers Squibb's liso-cel facility and the CVR, but analysts urge caution
Endpoints
Tue, 12/8/20 - 10:41 am
Tags:
Bristol-Myers Squibb
,
liso-cel
,
drug manufacturing
,
Celgene
,
CVRs
Bristol Myers' $9 Celgene CVR is teetering on the brink of disaster as the FDA delays the liso-cel application yet again
Endpoints
Mon, 11/16/20 - 10:42 pm
Tags:
Bristol-Myers Squibb
,
CVRs
,
Celgene
,
M&A
Bristol Myers Squibb execs tout progress on Zeposia, Reblozyl and Onureg launches
Fierce Pharma
Fri, 11/6/20 - 12:38 am
Tags:
Celgene
,
Bristol-Myers Squibb
,
Zeposia
,
Reblozyl
,
Onureg
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.